Clinical Trial Update: Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of APSTZD for insomnia disorder; the trial status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• APSTZD

Snippet

Sponsor: Apsen Farmaceutica S.A. | Conditions: Insomnia, Insomnia Chronic | Phase 2 | Status: NOT_YET_RECRUITING